Network with MHRA, Sandoz, Boehringer Ingelheim, Sanofi, Teva and more | Biosimilars and Biobetters

LONDON - Sept. 23, 2015 - PRLog -- With the event now 1 week away, I would like to remind you that this is the final chance to secure a place for SMi's 6th annual conference on Biosimilars and Biobetters, taking place on the 30th September - 1st October 2015 in Central London.

Following the breakthroughs in the US, this is the only European Biosimilars and Biobetters meeting which gathers global industry experts to discuss the latest issues with technical case studies. You will hear regulatory updates and developments in the biosimilar commercial environment from MHRA, Merck Serono, Teva, Cinfa Biotech, Norwegian Medicines Agency and many more.

Don’t miss out on this 2-day conference which includes:
• 16 case studies + 2 in-depth workshops to drive commercial success
• 2 interactive panel discussions to learn from your industry colleagues
• 3 hours of valuable networking sessions
• Meeting biosimilars leaders outside of Europe

View the full speaker line-up and two-day conference programme at http://www.smi-online.co.uk/2015biosimilars1.asp

Update on Confirmed Attendees
Join us next week and network with Biosimilars and Biobetters professionals from:
• AbbVie
• Alston & Bird LLP
• Anteris Medical GmbH
• Arnold & Porter LLP
• Boehringer Ingelheim
• Bristows
• Cinfa Biotech
• Ecole Normale Supérieure de Cachan
• Eppendorf AG
• Fresenius Kabi
• GfK
• Globyz Pharma
• Grifols
• IMS Health
• Invest Lithuania
• Italfarmaco S.p.A.
• Kantar Health
• Kinesys Consulting
• Merck Serono
• MHRA
• Mundipharma International
• Newcastle University
• Norwegian Medicines Agency
• Orion Corporation
• Salamanca Group
• SAI MedPartners
• Sandoz
• Sanofi
• Schwegman, Lundberg & Woessner
• Selecta Biosciences
• SGS Life Sciences Services
• SGS M-Scan SA
• Teva
• University of Basel
• Venner Shipley LLP
• Wyatt Health Management
plus many more....

Plus, don't miss two interactive conference workshops:

Workshop A | 1:00pm - 5.30pm | 29th September 2015
Assessing the Regulatory Framework for Europe and the US – Developing Future Biologics
Led by: Fiona Greer, Global Director, Biopharmaceutical Services Development, SGS M-Scan SA and Lincoln Tsung, Daniel Kracov, Jennifer Sklenar, Partners, Arnold & Porter (UK) LLP

Workshop B | 8:30am - 12.30pm | 2nd October 2015
Biosimilars - Understanding the Regulatory Processes and the Commercial Realities
Led by: Peter Wittner, Senior Consultant, Interpharm Consultancy